Fig. 3From: Synergistic mechanism of Bacillus subtilis Czk1 combined with propiconazole and tebuconazole mixtures against Pyrrhoderma noxiumDifferential metabolite KEGG pathway enrichment. a ESI+; b: ESI−Back to article page